Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study.
暂无分享,去创建一个
P. Barter | J. Kastelein | S. Boekholdt | D. Demicco | K. Rye | J. Davaine | W. Bao | B. Arsenault | F. Tabet | G. Lambert | R. Huijgen | F. Petrides | G. Lambert